You Searched For: Dopamine+hydrochloride

Supplier: BeanTown Chemical

Description: CAS: 62-31-7; EC No: 200-527-8; MDL No: MFCD00012898; RTECS: UX1092000 Powder; Molecular Formula: C8H11NO2·HCl; MW: 189.64 Melting Point: 248-250° Hygroscopic , Light Sensitive

SDS

Catalog Number: (101094-874)

Supplier: USP

Description: (200 mg)

SDS

Supplier: Thermo Scientific Chemicals

Description: A neurotransmitter and vasopressor that modulates cortical activation

SDS Certificates

Supplier: TCI America

Description: CAS Number: 62-31-7
MDL Number: MFCD00012898
Molecular Formula: C8H11NO2
Molecular Weight: 189.64
Purity/Analysis Method: >98.0% (HPLC,N)
Form: Crystal

SDS Certificates

Catalog Number: (89157-300)

Supplier: Enzo Life Sciences

Description: Dopamine receptor ligand.

Catalog Number: (89160-846)

Supplier: Enzo Life Sciences

Description: Inhibitor of dopamine and norepinephrine transporters

Catalog Number: (77694-297)

Supplier: LGC Standards

Description: Dopamine-d4 Hydrochloride, TRC, LGC Standards

New Product

Supplier: Thermo Scientific Chemicals

Description: A selective inhibitor of dopamine uptake

SDS Certificates

Supplier: Thermo Scientific Chemicals

Description: Dopamine agonist

SDS Certificates

Supplier: Thermo Scientific Chemicals

Description: 5-HT3 serotonin antagonist; D2 dopamine antagonist

SDS Certificates

Catalog Number: (AAJ63830-MF)

Supplier: Thermo Scientific Chemicals

Description: An NMDA receptor antagonist; stimulates dopamine release

SDS Certificates

Supplier: MP Biomedicals

Description: Chlorpromazine Hydrochloride is a phenothiazine antipsychotic; a D2 and H1 antagonist. It inhibits calmodulin-dependent stimulation of cyclic nucleotide phosphodiesterase and nitric oxide synthase and is reported to uncouple and inhibit oxidative phosphorylation at 10-3 - 10-4 M. It is possibly a photogenotoxic agent in humans. Helps to induce hypothermia in mice in the dose range of 12.5 -100 mg/kg.
Chlorpromazine demonstrates cytotoxic and antiproliferative activity against leukemic cells, but does not affect the viability of normal lymphocytes.

Phenothiazine antipsychotic; D2 dopamine receptor antagonist, H1 histamine receptor antagonist; inhibits calmodulin-dependent stimulation of cyclic nucleotide phosphodiesterase and nitric oxide synthase.

Catalog Number: (10336-536)

Supplier: Bioss

Description: Methamphetamine (METH) is closely related chemically to amphetamine (AMPH). METH is a potent central nervous system stimulant with additional peripheral sympathomimetic effects. METH and AMPH have been used clinically in the treatment of obesity, minimal brain dysfunction, narcolepsy, depression and to counter fatigue. They are also subjected to widespread abuse. METH is an indirect agonists. It causes the release of newly synthesized norepinephrine and dopamine and it blocks the re uptake of these transmitters from the synapse. This can lead to an increase in the concentration of catecholamines in the synapse as well as an overall increase in catecholaminergic activity in the brain. The mechanism of METH induced neurotoxicity for all monoaminergic cell types may lie primarily with the dopaminergic system in the striatum. It may also lie with the interaction between METH induced release of dopamine and its ability to inhibit monoamine oxidase.

Catalog Number: (76101-626)

Supplier: Bioss

Description: Methamphetamine (METH) is closely related chemically to amphetamine (AMPH). METH is a potent central nervous system stimulant with additional peripheral sympathomimetic effects. METH and AMPH have been used clinically in the treatment of obesity, minimal brain dysfunction, narcolepsy, depression and to counter fatigue. They are also subjected to widespread abuse. METH is an indirect agonists. It causes the release of newly synthesized norepinephrine and dopamine and it blocks the re uptake of these transmitters from the synapse. This can lead to an increase in the concentration of catecholamines in the synapse as well as an overall increase in catecholaminergic activity in the brain. The mechanism of METH induced neurotoxicity for all monoaminergic cell types may lie primarily with the dopaminergic system in the striatum. It may also lie with the interaction between METH induced release of dopamine and its ability to inhibit monoamine oxidase.

Catalog Number: (10336-514)

Supplier: Bioss

Description: Methamphetamine (METH) is closely related chemically to amphetamine (AMPH). METH is a potent central nervous system stimulant with additional peripheral sympathomimetic effects. METH and AMPH have been used clinically in the treatment of obesity, minimal brain dysfunction, narcolepsy, depression and to counter fatigue. They are also subjected to widespread abuse. METH is an indirect agonists. It causes the release of newly synthesized norepinephrine and dopamine and it blocks the re uptake of these transmitters from the synapse. This can lead to an increase in the concentration of catecholamines in the synapse as well as an overall increase in catecholaminergic activity in the brain. The mechanism of METH induced neurotoxicity for all monoaminergic cell types may lie primarily with the dopaminergic system in the striatum. It may also lie with the interaction between METH induced release of dopamine and its ability to inhibit monoamine oxidase.

Catalog Number: (76101-628)

Supplier: Bioss

Description: Methamphetamine (METH) is closely related chemically to amphetamine (AMPH). METH is a potent central nervous system stimulant with additional peripheral sympathomimetic effects. METH and AMPH have been used clinically in the treatment of obesity, minimal brain dysfunction, narcolepsy, depression and to counter fatigue. They are also subjected to widespread abuse. METH is an indirect agonists. It causes the release of newly synthesized norepinephrine and dopamine and it blocks the re uptake of these transmitters from the synapse. This can lead to an increase in the concentration of catecholamines in the synapse as well as an overall increase in catecholaminergic activity in the brain. The mechanism of METH induced neurotoxicity for all monoaminergic cell types may lie primarily with the dopaminergic system in the striatum. It may also lie with the interaction between METH induced release of dopamine and its ability to inhibit monoamine oxidase.